SE420716B - Forfarande for framstellning av nya 2-aminometyl-4,6-diahalogenofenolderivat - Google Patents

Forfarande for framstellning av nya 2-aminometyl-4,6-diahalogenofenolderivat

Info

Publication number
SE420716B
SE420716B SE7317226A SE7317226A SE420716B SE 420716 B SE420716 B SE 420716B SE 7317226 A SE7317226 A SE 7317226A SE 7317226 A SE7317226 A SE 7317226A SE 420716 B SE420716 B SE 420716B
Authority
SE
Sweden
Prior art keywords
diahalogenophenold
aminomethyl
derivatives
procedure
preparation
Prior art date
Application number
SE7317226A
Other languages
English (en)
Swedish (sv)
Inventor
L H Schlager
Original Assignee
Gerot Pharmazeutika
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT173A external-priority patent/AT319915B/de
Application filed by Gerot Pharmazeutika filed Critical Gerot Pharmazeutika
Publication of SE420716B publication Critical patent/SE420716B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7317226A 1973-01-02 1973-12-20 Forfarande for framstellning av nya 2-aminometyl-4,6-diahalogenofenolderivat SE420716B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AT173A AT319915B (de) 1973-01-02 1973-01-02 Verfahren zur Herstellung von neuen 2-Aminomethyl-4,6-dihalogenphenolderivaten sowie deren Salzen mit physiologisch verträglichen Säuren oder Basen
AT738773A AT332863B (de) 1973-01-02 1973-08-24 Verfahren zur herstellung von neuen 2-aminomethyl-4,6-dihalogenphenolderivaten sowie deren additionssalzen mit sauren
BE152177A BE824138R (fr) 1973-01-02 1975-01-06 Procede de preparation de nouveaux derives d'aminomethyl-2 dihalo-4,6-phenol
BE824138 1975-01-06

Publications (1)

Publication Number Publication Date
SE420716B true SE420716B (sv) 1981-10-26

Family

ID=27421065

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7317226A SE420716B (sv) 1973-01-02 1973-12-20 Forfarande for framstellning av nya 2-aminometyl-4,6-diahalogenofenolderivat

Country Status (16)

Country Link
US (1) US3996278A (ru)
JP (1) JPS5335065B2 (ru)
AT (1) AT332863B (ru)
BE (1) BE824138R (ru)
BG (1) BG24226A3 (ru)
CA (1) CA1090340A (ru)
CH (1) CH610292A5 (ru)
CS (1) CS183634B2 (ru)
DD (1) DD113526A5 (ru)
DE (1) DE2364191C2 (ru)
DK (1) DK309774A (ru)
FR (1) FR2212145B1 (ru)
GB (1) GB1460761A (ru)
NL (1) NL167414C (ru)
SE (1) SE420716B (ru)
SU (1) SU1091852A3 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2287219A2 (fr) * 1974-10-11 1976-05-07 Gerot Pharmazeutika Nouveaux derives 2-aminomethyl-4,6-dinalophenoliques et leur procede de preparation
DE2934508A1 (de) * 1978-09-06 1980-03-20 Sandoz Ag Alpha -alkyl-o-oxybenzylamin- derivate, ihre herstellung und sie enthaltende heilmittel
CA1219587A (en) * 1981-12-14 1987-03-24 Norman P. Jensen Hydroxybenzylaminobenzenes as anti-inflammatory agents
US4578390A (en) * 1981-12-14 1986-03-25 Merck & Co., Inc. Hydroxybenzylamino derivatives as anti-inflammatory agents
FR2661176B1 (fr) * 1990-04-20 1992-06-12 Adir Nouveau procede de preparation de la 1-(2,3,4-trimethoxybenzyl) piperazine en amination reductive.
ZA923283B (en) * 1991-05-29 1993-01-27 Akzo Nv Phenoxyphenyl derivatives
JP2007513082A (ja) * 2003-11-10 2007-05-24 シエーリング アクチエンゲゼルシャフト Ccr−5アンタゴニストとして有用なベンジルエーテルアミン化合物
CN103833588B (zh) * 2012-11-16 2015-09-23 上海医药工业研究院 酰胺类化合物的两种晶型、制备方法及其应用
CN113214097B (zh) * 2020-01-21 2022-08-30 厦门大学 治疗阿尔茨海默病的化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2806063A (en) * 1956-04-23 1957-09-10 Dow Chemical Co Amine salts of chlorophenols
BE562425A (ru) 1956-11-16
US3227756A (en) * 1962-07-10 1966-01-04 Velsicol Chemical Corp N,n-mono- and di-substituted-aralkyl amines
US3864401A (en) 1970-12-23 1975-02-04 Merck & Co Inc Substituted 2-aminomethyl-4,6-dihalophenols
US3809721A (en) * 1970-12-23 1974-05-07 Merck & Co Inc Substituted 2-aminomethyl-4,6-disubstituted phenols
NL180978C (nl) * 1972-10-23 1987-06-01 Thomae Gmbh Dr K Werkwijze voor het vervaardigen van een farmaceutisch preparaat met secretorische en/of hoeststillende werking, en werkwijze voor het bereiden van een verbinding geschikt voor toepassing bij voornoemde werkwijze.

Also Published As

Publication number Publication date
DE2364191A1 (de) 1974-07-11
DK309774A (ru) 1975-04-28
CH610292A5 (ru) 1979-04-12
US3996278A (en) 1976-12-07
AU7087774A (en) 1976-01-08
GB1460761A (en) 1977-01-06
CA1090340A (en) 1980-11-25
NL167414C (nl) 1981-12-16
SU1091852A3 (ru) 1984-05-07
CS183634B2 (en) 1978-07-31
BE824138R (fr) 1975-07-07
FR2212145B1 (ru) 1977-01-28
BG24226A3 (en) 1978-01-10
ATA738773A (de) 1976-02-15
NL7317753A (ru) 1974-07-04
JPS49100043A (ru) 1974-09-20
DD113526A5 (ru) 1975-06-12
DE2364191C2 (de) 1986-06-12
FR2212145A1 (ru) 1974-07-26
JPS5335065B2 (ru) 1978-09-25
AT332863B (de) 1976-10-25
NL167414B (nl) 1981-07-16

Similar Documents

Publication Publication Date Title
SE420201B (sv) Forfarande for framstellning av nya 7alfa-metoxicefalosporinderivat
SE7710600L (sv) Forfarande for framstellning av 1,3-bensoxazoler
SE424994B (sv) Forfarande for framstellning av nya pseudotrisackarider
SE416731B (sv) Forfarande for framstellning av nya penicilliner
SE420604B (sv) Forfarande for framstellning av oxazolderivat
SE424863B (sv) Analogiforfarande for framstellning av nya isokinolinderivat
NO143531C (no) Fremgangsmaate for fremstilling av acylerte benzoksazolinon-derivater.
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
SE420716B (sv) Forfarande for framstellning av nya 2-aminometyl-4,6-diahalogenofenolderivat
NO153806C (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin.
SE387341B (sv) Forfarande for framstellning av 1-aryl-n-dialkyl-aminoalkyl-3,4-dihydro2(h)-isokinolinkarboxamider
SE419443B (sv) Forfarande for framstellning av nya 2,4 diamino-5-bensylpyrimidinderivat
SE404801B (sv) Forfaranden for framstellning av nya tiazolderivat
SE419444B (sv) Forfarande for framstellning av nya 2,4-diamino-5-bensylpyrimidinderivat
SE402106B (sv) Forfarande for framstellning av nya n-(Ÿ-amino)-alkylanilinderivat
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE419549B (sv) Forfarande for framstellning av nya 7-(cyanometylaryl)acetamidocefalospotinderivat
SE7507481L (sv) Forfarande for framstellning av nya cefalosporinderivat.
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on
SE415975B (sv) Forfarande for framstellning av nya bensylpyrimidiner
SE409325B (sv) Forfarande for framstellning av kinazolinonderivat
SE7409006L (sv) Forfarande for frasmtellning av nya bifenyl-derivat.
SE409702B (sv) Forfarande for framstellning av glutamylamidderivat av dopamin